Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

XPeng Expects to Sell 600K Vehicles in 2026, Plans New SUV LaunchesPhoto, wide shot, wide-angle lens, soft focus,  Car rental company, sunset photo at golden hour, photo by Art Wolfe: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-Ew7cRec38UnlyYzs41FVEri5.png?st=2023-12-29T14%3A03%3A41Z&se=2023-12-29T16%3A03%3A41Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-12-29T15%3A03%3A25Z&ske=2023-12-30T15%3A03%3A25Z&sks=b&skv=2021-08-06&sig=vZPI3wL5I%2BC5Zknik6hYtwmYdTdsE1ct/DM1evRA8EI%3D
XPeng Expects to Sell 600K Vehicles in 2026, Plans New SUV Launches

XPeng Inc. XPEV, an electric vehicle manufacturer from China, is aiming to sell between 550,000 and 600,000 vehicles this year, per a report by Chinese technology outlet 36Kr. This target implies

Zacks Investment Ideas feature highlights: Wayfair, Robinhood and Palantir
Zacks Investment Ideas feature highlights: Wayfair, Robinhood and Palantir

For Immediate Release

Chicago, IL – January 15, 2026 – Today, Zacks Investment Ideas feature highlights Wayfair W, Robinhood HOOD and Palantir PLTR.

3 Companies Enjoying Snowballing Sales Growth

Wall Street Analysts Think Day One Biopharmaceuticals (DAWN) Could Surge 107.36%: Read This Before Placing a Bet
Wall Street Analysts Think Day One Biopharmaceuticals (DAWN) Could Surge 107.36%: Read This Before Placing a Bet

Shares of Day One Biopharmaceuticals, Inc. (DAWN) have gained 22.5% over the past four weeks to close the last trading session at $10.73, but there could still be a solid upside left in the stock if

Wall Street Analysts Think K12 (LRN) Could Surge 49.19%: Read This Before Placing a Bet
Wall Street Analysts Think K12 (LRN) Could Surge 49.19%: Read This Before Placing a Bet

K12 (LRN) closed the last trading session at $70.38, gaining 6.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

How Much Upside is Left in Immunovant (IMVT)? Wall Street Analysts Think 47.39%
How Much Upside is Left in Immunovant (IMVT)? Wall Street Analysts Think 47.39%

Immunovant, Inc. (IMVT) closed the last trading session at $27.35, gaining 1.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

Wall Street Analysts See a 28.45% Upside in Marex Group PLC (MRX): Can the Stock Really Move This High?
Wall Street Analysts See a 28.45% Upside in Marex Group PLC (MRX): Can the Stock Really Move This High?

Shares of Marex Group PLC (MRX) have gained 1.2% over the past four weeks to close the last trading session at $39.15, but there could still be a solid upside left in the stock if short-term price

After Golden Cross, Adeia (ADEA)'s Technical Outlook is Bright
After Golden Cross, Adeia (ADEA)'s Technical Outlook is Bright

After reaching an important support level, Adeia Inc. (ADEA) could be a good stock pick from a technical perspective. ADEA recently experienced a "golden cross" event, which saw its 50-day simple

Does KalVista Pharmaceuticals (KALV) Have the Potential to Rally 117.98% as Wall Street Analysts Expect?Photo, wide shot, wide-angle lens,  Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png
Does KalVista Pharmaceuticals (KALV) Have the Potential to Rally 117.98% as Wall Street Analysts Expect?

KalVista Pharmaceuticals, Inc. (KALV) closed the last trading session at $15.24, gaining 2.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price

Zacks Investment Ideas feature highlights: Kinross Gold, Agnico Eagle Mines and Royal Gold: https://pixabay.com/de/photos/gold-ingots-golden-schatz-513062/
Zacks Investment Ideas feature highlights: Kinross Gold, Agnico Eagle Mines and Royal Gold

For Immediate Release

Chicago, IL – January 15, 2026 – Today, Zacks Investment Ideas feature highlights Kinross Gold KGC, Agnico Eagle Mines AEM and Royal Gold RGLD.

Why Gold Mining Stocks May Still

Teledyne Acquires DD-Scientific, Expands Gas Sensing Portfolio
Teledyne Acquires DD-Scientific, Expands Gas Sensing Portfolio

Teledyne Technologies, Inc. TDY recently stated that it has acquired DD-Scientific Holdings Limited and its subsidiary DD-Scientific Limited, a leading developer and manufacturer of high-performance

Here's Why Vertiv Holdings Co. (VRT) is a Strong Momentum Stock
Here's Why Vertiv Holdings Co. (VRT) is a Strong Momentum Stock

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

Featuring daily updates

Here's Why Viking Holdings (VIK) is a Strong Momentum Stock
Here's Why Viking Holdings (VIK) is a Strong Momentum Stock

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The popular research

Teva Pharmaceutical Industries Ltd. (TEVA) is a Top-Ranked Momentum Stock: Should You Buy?Photo, wide shot, wide-angle lens,  Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png
Teva Pharmaceutical Industries Ltd. (TEVA) is a Top-Ranked Momentum Stock: Should You Buy?

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

Featuring daily updates

Here's Why Sun Life (SLF) is a Strong Momentum Stock
Here's Why Sun Life (SLF) is a Strong Momentum Stock

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

Featuring daily updates

Here's Why BJ's Restaurants (BJRI) is a Strong Momentum Stock
Here's Why BJ's Restaurants (BJRI) is a Strong Momentum Stock

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Here's Why Ryder (R) is a Strong Momentum Stock
Here's Why Ryder (R) is a Strong Momentum Stock

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Jack Henry (JKHY) is a Top-Ranked Momentum Stock: Should You Buy?
Jack Henry (JKHY) is a Top-Ranked Momentum Stock: Should You Buy?

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Why Exelixis (EXEL) is a Top Momentum Stock for the Long-Term
Why Exelixis (EXEL) is a Top Momentum Stock for the Long-Term

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The research service

Why Casey's General Stores (CASY) is a Top Momentum Stock for the Long-Term
Why Casey's General Stores (CASY) is a Top Momentum Stock for the Long-Term

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Why Axsome Therapeutics (AXSM) is a Top Momentum Stock for the Long-Term
Why Axsome Therapeutics (AXSM) is a Top Momentum Stock for the Long-Term

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Here's Why AAR (AIR) is a Strong Momentum Stock
Here's Why AAR (AIR) is a Strong Momentum Stock

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The research service

Cisco Stock Rises 8% in 3 Months: Will the Rally Continue in 2026?
Cisco Stock Rises 8% in 3 Months: Will the Rally Continue in 2026?

Cisco Systems CSCO shares returned 7.7% in the trailing 3-month period, outperforming the broader Zacks Computer & Technology sector, as well as close peers, Hewlett Packard Enterprise HPE and

Shopify Trades 14% Below 52-Week High: Buy, Sell or Hold the Shares?
Shopify Trades 14% Below 52-Week High: Buy, Sell or Hold the Shares?

Shopify SHOP shares closed at $157.51 on Wednesday, which was 14% lower than the 52-week high of $182.19 it hit on Oct. 29. SHOP shares have jumped 52.2% in a year, outperforming the broader Zacks

Can Brand Diversification Shield PPC From Commodity Volatility?Photo, wide shot, wide-angle lens,  Gold mine, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/94faf2bd-99c1-4ea6-b55d-fdcab23c3865.png
Can Brand Diversification Shield PPC From Commodity Volatility?

Pilgrim's Pride Corporation PPC has been leaning more heavily on brand and portfolio diversification to help manage the volatility inherent in commodity-driven poultry markets. The company’s

Bayer Stock Jumps on Nubeqa Outlook, Presents Pharma StrategyPhoto, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.theapi.app/temp/0e9d087d-988e-4397-b7cf-6049e2776769.png
Bayer Stock Jumps on Nubeqa Outlook, Presents Pharma Strategy

Shares of German pharma giant Bayer AG BAYRY gained 6.6% on Jan. 14, following an update by partner Orion, a Finnish pharmaceutical company.

Orion believes that long-term annual net sales from